lamotrigine has been researched along with Migraine Disorders in 16 studies
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Migraine is a common cause of vertigo." | 5.32 | Treatment of migraine related vertigo with lamotrigine an observational study. ( Bisdorff, AR, 2004) |
| "Lamotrigine was most effective in trigeminal neuralgia and dysesthesia, but was of little utility in the other head or facial pains." | 3.80 | New generation anti-epileptics for facial pain and headache. ( Delvaux, V; Schoenen, J, 2001) |
| "Sixty patients with frequent migraine (more than 4 attacks per month) from the headache clinic at a tertiary referral centre in India were randomized to receive 50 mg topiramate/lamotrigine or matching placebo for 1 month each in 2 divided doses in 4 phases in a crossover manner with a washout period of 7 days in between." | 2.73 | Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). ( Behari, M; Goyal, V; Gupta, P; Shukla, G; Singh, S, 2007) |
| "Thirteen patients suffering from migraine with aura and 2 patients with aura but without migraine were enrolled and treated with lamotrigine." | 2.69 | Lamotrigine in the prophylactic treatment of migraine aura--a pilot study. ( Buzath, A; Klinger, D; Lampl, C; Neumann, K, 1999) |
| "We studied 24 patients affected by migraine with aura with a high frequency of attacks." | 2.69 | Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. ( Cadaldini, M; D'Andrea, G; Granella, F; Manzoni, GC, 1999) |
| "The TACs include cluster headache, paroxysmal hemicrania, and short-lasting neuralgiform headache attacks with conjunctival injection and tearing; hemicrania continua, although classified separately by the International Headache Society, shares many features of both migraine and the TACs." | 2.49 | Primary headache disorders. ( Benoliel, R; Eliav, E, 2013) |
| "Topiramate was more likely prescribed for those with comorbid headache or migraine (incident: 335 of 1251 [26." | 1.51 | Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. ( Faught, E; Fishman, J; Kalilani, L; Kim, H; Thurman, DJ, 2019) |
| "Lamotrigine was the most frequently initiated drug in psychiatry, in both boys and girls." | 1.48 | Utilization of Antiepileptic Medicines in Swedish Children and Adolescents with Different Diagnoses. ( Karlsson Lind, L; von Euler, M; Wettermark, B; Wide, K, 2018) |
| "Background The impact of adverse events (AEs) of antiepileptic drugs (AEDs) have an impact on compliance and dropouts." | 1.48 | Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? ( Bedetti, C; Calabresi, P; Caproni, S; Corbelli, I; Costa, C; Cupini, LM; Eusebi, P; Romoli, M; Sarchielli, P; Siliquini, S, 2018) |
| "Because chronic treatment with migraine prophylactic drugs suppresses SD susceptibility, we tested whether migraine prophylaxis can also suppress ischemic depolarizations and improve stroke outcome." | 1.42 | Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice. ( Ayata, C; Can, A; Daneshmand, A; Eikermann-Haerter, K; Ferrari, MD; Lee, JH; Sengul, B; van den Maagdenberg, AM; Wei, Y; Yalcin, N; Yu, ES; Zheng, Y, 2015) |
| "Lamotrigine has a marked suppressive effect which correlates with its rather selective action on the migraine aura." | 1.37 | Migraine preventive drugs differentially affect cortical spreading depression in rat. ( Bogdanov, VB; Bogdanova, OV; Chauvel, V; Makarchuk, MY; Multon, S; Prodanov, D; Schoenen, J, 2011) |
| "Migraine is a common cause of vertigo." | 1.32 | Treatment of migraine related vertigo with lamotrigine an observational study. ( Bisdorff, AR, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Groenke, BR | 1 |
| Daline, IH | 1 |
| Nixdorf, DR | 1 |
| Karlsson Lind, L | 1 |
| Wide, K | 1 |
| Wettermark, B | 1 |
| von Euler, M | 1 |
| Kim, H | 1 |
| Faught, E | 1 |
| Thurman, DJ | 1 |
| Fishman, J | 1 |
| Kalilani, L | 1 |
| Benoliel, R | 1 |
| Eliav, E | 1 |
| Eikermann-Haerter, K | 1 |
| Lee, JH | 1 |
| Yalcin, N | 1 |
| Yu, ES | 1 |
| Daneshmand, A | 1 |
| Wei, Y | 1 |
| Zheng, Y | 1 |
| Can, A | 1 |
| Sengul, B | 1 |
| Ferrari, MD | 1 |
| van den Maagdenberg, AM | 1 |
| Ayata, C | 1 |
| Romoli, M | 1 |
| Costa, C | 1 |
| Siliquini, S | 1 |
| Corbelli, I | 1 |
| Eusebi, P | 1 |
| Bedetti, C | 1 |
| Caproni, S | 1 |
| Cupini, LM | 1 |
| Calabresi, P | 1 |
| Sarchielli, P | 1 |
| Bogdanov, VB | 1 |
| Multon, S | 1 |
| Chauvel, V | 1 |
| Bogdanova, OV | 1 |
| Prodanov, D | 1 |
| Makarchuk, MY | 1 |
| Schoenen, J | 2 |
| Ortiz, A | 1 |
| Alda, M | 1 |
| O'Donovan, C | 1 |
| Bisdorff, AR | 1 |
| Gupta, P | 1 |
| Singh, S | 1 |
| Goyal, V | 1 |
| Shukla, G | 1 |
| Behari, M | 1 |
| Mathew, NT | 1 |
| Steiner, TJ | 1 |
| Findley, LJ | 1 |
| Yuen, AW | 1 |
| Nicolodi, M | 1 |
| Del Bianco, PL | 1 |
| Sicuteri, F | 1 |
| Lampl, C | 1 |
| Buzath, A | 1 |
| Klinger, D | 1 |
| Neumann, K | 1 |
| D'Andrea, G | 1 |
| Granella, F | 1 |
| Cadaldini, M | 1 |
| Manzoni, GC | 1 |
| Delvaux, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas[NCT04759196] | Phase 4 | 56 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for lamotrigine and Migraine Disorders
| Article | Year |
|---|---|
Primary headache disorders.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anticonvulsants; Chronic Disease; Cluster Headache; Cycloox | 2013 |
New generation anti-epileptics for facial pain and headache.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Facial Pain; Humans; Lamotrigine; Middle Aged; Migr | 2001 |
5 trials available for lamotrigine and Migraine Disorders
| Article | Year |
|---|---|
Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
Topics: Adolescent; Adult; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combina | 2007 |
Lamotrigine versus placebo in the prophylaxis of migraine with and without aura.
Topics: Adolescent; Adult; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Lamotrigine; Male; | 1997 |
Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.
Topics: Adolescent; Adult; Excitatory Amino Acid Antagonists; Female; Humans; Lamotrigine; Male; Middle Aged | 1999 |
Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study.
Topics: Adolescent; Adult; Analgesics; Female; Humans; Lamotrigine; Male; Middle Aged; Migraine Disorders; P | 1999 |
New generation anti-epileptics for facial pain and headache.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Facial Pain; Humans; Lamotrigine; Middle Aged; Migr | 2001 |
10 other studies available for lamotrigine and Migraine Disorders
| Article | Year |
|---|---|
SUNCT/SUNA: Case series presenting in an orofacial pain clinic.
Topics: Adult; Autonomic Nervous System Diseases; Facial Pain; Female; Gabapentin; Headache Disorders; Human | 2021 |
Utilization of Antiepileptic Medicines in Swedish Children and Adolescents with Different Diagnoses.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Prescriptions; Drug Utilization; Epilepsy | 2018 |
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Anxiety Disorders; Comorbidity; Dissociative Disorders; Epilepsi | 2019 |
Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice.
Topics: Animals; Anticonvulsants; Brain Ischemia; Calcium Channels, N-Type; Chemoprevention; Cortical Spread | 2015 |
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Epilepsy; Female; Humans; Lamotr | 2018 |
Migraine preventive drugs differentially affect cortical spreading depression in rat.
Topics: Animals; Anticonvulsants; Cortical Spreading Depression; Lamotrigine; Male; Migraine Disorders; Rats | 2011 |
Tourette syndrome with comorbid bipolar disorder and migraine: can lamotrigine monotherapy help?
Topics: Adult; Bipolar Disorder; Brain; Comorbidity; Compulsive Behavior; Female; Follow-Up Studies; Halluci | 2012 |
Treatment of migraine related vertigo with lamotrigine an observational study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Female; Headache; Humans; Lamotrigine; Male; Middle Aged | 2004 |
Valproate and lamotrigine in migraine.
Topics: Calcium Channel Blockers; Humans; Lamotrigine; Migraine Disorders; Triazines; Valproic Acid | 1997 |
Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse.
Topics: Acetates; Adult; Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagon | 1997 |